Search research articles
Contact Us
Filters
Showing results (11-20 of 99) with videos related to
Page
of 10
Sort By:
Pigment Cell & Melanoma Research
|
May 8, 2019
IL-17A is not a treatment target in progressive vitiligo
Reinhart Speeckaert, Sofie Mylle, Nanja van Geel
JAMA Dermatology
|
August 25, 2016
Clinical Significance of Serum Soluble CD Molecules to Assess Disease Activity in Vitiligo
Reinhart Speeckaert, Jo Lambert, Nanja van Geel
The Journal of Investigative Dermatology
|
February 28, 2017
Alterations of CXCL12 in Serum of Patients with Vitiligo
Reinhart Speeckaert, Katia Ongenae, Nanja van Geel
Pigment Cell & Melanoma Research
|
September 27, 2023
A meta-analysis of the placebo response in vitiligo: Causes and consequences for the interpretation of clinical trials
Reinhart Speeckaert, Marijn M Speeckaert, Nanja van Geel
Autoimmunity Reviews
|
December 16, 2014
Why treatments do(n't) work in vitiligo: An autoinflammatory perspective
Reinhart Speeckaert, Marijn M Speeckaert, Nanja van Geel
Antioxidants (Basel, Switzerland)
|
September 28, 2024
The Multifaceted Aspects of Oxidative Stress in the Skin and Other Tissues
Reinhart Speeckaert, Marijn M Speeckaert, Nanja van Geel
The Journal of Investigative Dermatology
|
February 19, 2017
S100B Is a Potential Disease Activity Marker in Nonsegmental Vitiligo
Reinhart Speeckaert, Sofie Voet, Esther Hoste, et al.
Lancet (London, England)
|
January 19, 2015
Vitiligo
Khaled Ezzedine, Viktoria Eleftheriadou, Maxine Whitton, et al.
Pigment Cell & Melanoma Research
|
March 17, 2022
The delicate relation between melanocytes and skin immunity: A game of hide and seek
Reinhart Speeckaert, Arno Belpaire, Marijn Speeckaert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 28, 2025
Personalized medicine in vitiligo: A guide for daily practice
Reinhart Speeckaert, Julien Seneschal, Albert Wolkerstorfer, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 99) with videos related to
Sort By:
Page
of 10
Pigment Cell & Melanoma Research
|
May 8, 2019
IL-17A is not a treatment target in progressive vitiligo
Reinhart Speeckaert, Sofie Mylle, Nanja van Geel
JAMA Dermatology
|
August 25, 2016
Clinical Significance of Serum Soluble CD Molecules to Assess Disease Activity in Vitiligo
Reinhart Speeckaert, Jo Lambert, Nanja van Geel
The Journal of Investigative Dermatology
|
February 28, 2017
Alterations of CXCL12 in Serum of Patients with Vitiligo
Reinhart Speeckaert, Katia Ongenae, Nanja van Geel
Pigment Cell & Melanoma Research
|
September 27, 2023
A meta-analysis of the placebo response in vitiligo: Causes and consequences for the interpretation of clinical trials
Reinhart Speeckaert, Marijn M Speeckaert, Nanja van Geel
Autoimmunity Reviews
|
December 16, 2014
Why treatments do(n't) work in vitiligo: An autoinflammatory perspective
Reinhart Speeckaert, Marijn M Speeckaert, Nanja van Geel
Antioxidants (Basel, Switzerland)
|
September 28, 2024
The Multifaceted Aspects of Oxidative Stress in the Skin and Other Tissues
Reinhart Speeckaert, Marijn M Speeckaert, Nanja van Geel
The Journal of Investigative Dermatology
|
February 19, 2017
S100B Is a Potential Disease Activity Marker in Nonsegmental Vitiligo
Reinhart Speeckaert, Sofie Voet, Esther Hoste, et al.
Lancet (London, England)
|
January 19, 2015
Vitiligo
Khaled Ezzedine, Viktoria Eleftheriadou, Maxine Whitton, et al.
Pigment Cell & Melanoma Research
|
March 17, 2022
The delicate relation between melanocytes and skin immunity: A game of hide and seek
Reinhart Speeckaert, Arno Belpaire, Marijn Speeckaert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 28, 2025
Personalized medicine in vitiligo: A guide for daily practice
Reinhart Speeckaert, Julien Seneschal, Albert Wolkerstorfer, et al.
Page
of 10